Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Elicio Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +7 vs. Q4 2024
- Shares held
- 1.59M
- +1.14M (+250.5%) vs. Q4 2024
- Total value
- $9.80M
- +$7.55M (+334.8%) vs. Q4 2024
- New holders
- 9
- 8 more added
- Sold out
- 2
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 630,915 | $3.89M | 2.53% | +630,915 | New |
| Vanguard Group Inc | 321,694 | $1.98M | 0.00% | +75,871+30.9% | Added |
| Hudson Bay Capital Management LP | 182,734 | $1.13M | 0.01% | +182,734 | New |
| Geode Capital Management, LLC | 77,467 | $477.3K | 0.00% | +6,746+9.5% | Added |
| CM Management, LLC | 55,000 | $338.8K | 0.34% | +15,000+37.5% | Added |
| Millennium Management LLC | 52,218 | $321.7K | 0.00% | +52,218 | New |
| Northern Trust Corp | 51,855 | $319.4K | 0.00% | +21,086+68.5% | Added |
| BlackRock, Inc. | 39,323 | $242.2K | 0.00% | +19,512+98.5% | Added |
| Royal Bank of Canada | 36,537 | $225.0K | 0.00% | +36,537 | New |
| Susquehanna International Group, LLP | 31,361 | $193.2K | 0.00% | +31,361 | New |
| State Street Corp | 21,600 | $133.1K | 0.00% | −300−1.4% | Reduced |
| UBS Group AG | 21,198 | $130.6K | 0.00% | +21,181+124,594.1% | Added |
| Quantinno Capital Management LP | 20,000 | $123.2K | 0.00% | +20,000 | New |
| Jane Street Group, LLC | 14,993 | $92.4K | 0.00% | +14,993 | New |
| Meyer Handelman Co | 13,899 | $85.6K | 0.00% | 00.0% | Unchanged |
| Moody Lynn & Lieberson, LLC | 10,000 | $61.6K | 0.00% | +10,000 | New |
| CIBC Private Wealth Group, LLC | 7,000 | $42.6K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1,554 | $9.57K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,205 | $7.42K | 0.00% | +8+0.7% | Added |
| Morgan Stanley | 842 | $5.19K | 0.00% | +612+266.1% | Added |
| FMR LLC | 185 | $1.14K | 0.00% | +185 | New |
| SBI Securities Co., Ltd. | 83 | $511 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 65 | $400 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16 | $99 | 0.00% | −2−11.1% | Reduced |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −611−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −374−100.0% | Sold out |